Research Group of Microbiology, Department of Bio-engineering Sciences, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium.
LABIRIS Institut de Recherches, Av. Emile Gryson 1, 1070, Brussels, Belgium.
Amino Acids. 2018 Dec;50(12):1647-1661. doi: 10.1007/s00726-018-2654-z. Epub 2018 Sep 20.
In all organisms, carbamoylphosphate (CP) is a precursor common to the synthesis of arginine and pyrimidines. In Escherichia coli and most other Gram-negative bacteria, CP is produced by a single enzyme, carbamoylphosphate synthase (CPSase), encoded by the carAB operon. This particular situation poses a question of basic physiological interest: what are the metabolic controls coordinating the synthesis and distribution of this high-energy substance in view of the needs of both pathways? The study of the mechanisms has revealed unexpected moonlighting gene regulatory activities of enzymes and functional links between mechanisms as diverse as gene regulation and site-specific DNA recombination. At the level of enzyme production, various regulatory mechanisms were found to cooperate in a particularly intricate transcriptional control of a pair of tandem promoters. Transcription initiation is modulated by an interplay of several allosteric DNA-binding transcription factors using effector molecules from three different pathways (arginine, pyrimidines, purines), nucleoid-associated factors (NAPs), trigger enzymes (enzymes with a second unlinked gene regulatory function), DNA remodeling (bending and wrapping), UTP-dependent reiterative transcription initiation, and stringent control by the alarmone ppGpp. At the enzyme level, CPSase activity is tightly controlled by allosteric effectors originating from different pathways: an inhibitor (UMP) and two activators (ornithine and IMP) that antagonize the inhibitory effect of UMP. Furthermore, it is worth noticing that all reaction intermediates in the production of CP are extremely reactive and unstable, and protected by tunneling through a 96 Å long internal channel.
在所有生物体中,氨甲酰磷酸 (CP) 是合成精氨酸和嘧啶的共同前体。在大肠杆菌和大多数其他革兰氏阴性菌中,CP 是由单个酶,即氨甲酰磷酸合酶 (CPSase) 产生的,该酶由 carAB 操纵子编码。这种特殊情况提出了一个基本生理兴趣的问题:鉴于这两种途径的需求,如何协调这种高能物质的合成和分配的代谢控制?对这些机制的研究揭示了意想不到的酶的兼职基因调控活性和基因调控等不同机制之间的功能联系与位点特异性 DNA 重组。在酶生产水平上,发现了各种调节机制在一对串联启动子的特别复杂的转录控制中协同作用。转录起始受几种变构 DNA 结合转录因子的相互作用调节,这些转录因子使用来自三种不同途径(精氨酸、嘧啶、嘌呤)、核基质相关因子(NAPs)、触发酶(具有第二种不相关基因调控功能的酶)、DNA 重塑(弯曲和包裹)、依赖于 UTP 的反复转录起始和由警报素 ppGpp 进行的严格控制的效应分子来调节。在酶水平上,CPSase 活性受到来自不同途径的变构效应物的严格控制:一种抑制剂 (UMP) 和两种激活剂 (鸟氨酸和 IMP),它们拮抗 UMP 的抑制作用。此外,值得注意的是,CP 生产中的所有反应中间体都非常反应性和不稳定,并通过穿过 96 Å 长的内部通道进行保护。